Expression of p53 in adenocarcinoma of the gallbladder and bile ducts

Liver

Volumn 16, Issue 2, 1996, Pages 99-104

  Washington, Kay ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cholangiocarcinoma; Gallbladder neoplasms; Immunohistochemistry; Protein p53

Indexed keywords

ANTIBODY; CITRIC ACID; GENE PRODUCT; MONOCLONAL ANTIBODY; PROTEIN P53;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER SURVIVAL; CLINICAL ARTICLE; DYSPLASIA; FEMALE; GALLBLADDER CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROWAVE RADIATION; POINT MUTATION; PROGNOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0029871026     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1996.tb00712.x     Document Type: Article

References (14)

1. GREENBLATT M S, BENNETT W P, HOLLSTEIN M, HARRIS C C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994: 54: 4855-4878.
2. LEVINE A J, MOMAND J, FINLAY C A. The p53 tumor suppressor gene. Nature 1991: 351: 453-456.
3. KELLER J W, PEACOCK J L, SMITH J L. Cancer of the digestive glands: pancreas, liver, bile ducts, gallbladder. In: Rubin P, ed. Clinical oncology: a multidisciplinary approach for physicians and students, 7th edn. Philadelphia: W. B. Saunders Company, 1993: 597-615.
4. American Joint Committee for Cancer Staging and End-results Reporting. Manual for staging cancer, 3rd edn. Philadelphia: JB Lippincott Co., 1988.
5. KIKUCHI-YANOSHITA R, KONISHI M, ITO S, et al. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res 1992: 52: 3965-3971.
6. KAMEL D. PÄÄKKÖ P, NUORVA K, VÄHÄKANGAS K, SOINI Y. p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder. J Pathol 1993: 170: 67-72.
7. TEH M, WEE A, RAJU G C. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas. Cancer 1994: 74: 1542-1545.
8. TAKAGI S, NAITO E, YAMANOCHI H, OHTSUKA H, KOMINAMI R, YAMAMOTO M. Mutation of the p53 gene in gallbladder cancer Tohoku J Exp Med 1994: 172: 283-289.
9. KENNEDY S M, MACGEOGH C, JAFFE R, et al. Overexpression of the oncoprotein p53 in primary hepatic tumors of childhood does not correlate with gene mutations. Hum Pathol 1994: 25: 438-442.
10. HALL P A, LANE D P. p53 in tumour pathology: can we trust immunohistochemistry? Revisited. J Pathol 1994: 172: 1-4.
11. TERADA T, SHIMIZU K, IZUMI R, NAKANUMA Y. p53 expression in formalin-fixed, paraffin-embedded archival specimens of intrahepatic cholangiocarcinoma: retrieval of p53 antigenicity of microwave-oven heating of tissue sections. Mod Pathol 1994: 7: 249-252.
12. CHOI S W, HYTIROGLOU P, GELLER S A, KIM S M, CHUNG K W, PARK D H, THEISE N D, THUNG S W. The expression of p53 antigen in primary malignant epithelial tumors of the liver: an immunohistochemical study. Liver 1993: 13: 172-176.
13. NISHIHARA K, TSUNEYOSHI M. Undifferentiated spindle cell carcinoma of the gallbladder: a clinicopathologic. immunohistochemical, and flow cytometric study of 11 cases. Hum Pathol 1993: 24: 1298-1305.
14. HENSON D E, ALBORES-SAAVEDRA J, CORLE D. Carcinoma of the gallbladder: histologic types, stage of disease, grade, and survival rates. Cancer 1992: 70: 1493-1497.